Session 3 of workshop on "New Approaches to Accelerating Biomedical Innovation: Case Study on Appendiceal Cancer" held at MIT on April 11-12, 2023, and co-hosted by MIT's Laboratory for Financial Engineering and Koch Institute for Integrative Cancer Research.

Session Facilitator: Greg Simon, Simonovation LLC

Panelists:
- Christopher Austin, Vesalius Therapeutics
- Belen Carrillo-Rivas, Imvax
- Collin Hovinga, Critical Path Institute
- Philip Katz, Hogan Lovells US LLP
- Andrew von Eschenbach, Samaritan Health Initiatives
- Clarence Young, ProPharma Group

*The views and opinions expressed in this video are those of the speaker only and do NOT represent the views and opinions of Vesalius Therapeutics, Imvax, Critical Path Institute, Hogan Lovells US LLP, Samaritan Health Initiatives, ProPharma Group, MIT, any of their affiliates or employees, or any of the workshop organizers or participants.*